Carregant...

OnabotulinumtoxinA in the treatment of neurogenic bladder

This review examines the evidence for use of onabotulinumtoxinA in the treatment of neurogenic lower urinary tract dysfunction. Since its first use in 1988 to treat detrusor sphincter dyssynergia, use of botulinum toxin has increased in this group of patients. We discuss the mechanism of action, pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gulamhusein, Aziz, Mangera, Altaf
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437740/
https://ncbi.nlm.nih.gov/pubmed/22977301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S30180
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!